Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA:603456)
China · Delayed Price · Currency is CNY 15.07
-0.12 (-0.79%)
Sep 4, 2026, 3:00 PM CST
SHA:603456 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 13,157 | 15,783 | 12,247 | 21,777 | 35,397 | 46,842 | |
Market Cap Growth | -20.96% | 28.87% | -43.76% | -38.48% | -24.43% | 62.49% |
Enterprise Value | 10,331 | 13,276 | 10,155 | 18,935 | 34,444 | 46,532 |
Last Close Price | 15.07 | 17.76 | 13.15 | 22.42 | 38.69 | 51.07 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 22.54 | 21.62 | 20.21 | 21.08 | 38.43 | 73.90 |
Forward PE | 15.38 | 14.44 | 10.72 | 15.86 | 32.74 | 63.29 |
PS Ratio | 2.52 | 2.87 | 2.37 | 3.94 | 6.50 | 11.53 |
PB Ratio | 1.47 | 1.80 | 1.42 | 2.55 | 6.59 | 10.23 |
P/TBV Ratio | 1.56 | 1.91 | 1.54 | 2.78 | 7.48 | 11.44 |
P/FCF Ratio | 14.17 | 13.56 | 119.26 | 50.54 | 69.14 | 479.75 |
P/OCF Ratio | 8.59 | 8.65 | 12.35 | 16.01 | 28.88 | 69.14 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.98 | 2.41 | 1.97 | 3.43 | 6.33 | 11.45 |
EV/EBITDA Ratio | 7.65 | 8.97 | 9.08 | 12.80 | 25.17 | 45.74 |
EV/EBIT Ratio | 11.18 | 12.39 | 14.20 | 17.17 | 33.58 | 64.10 |
EV/FCF Ratio | 11.13 | 11.40 | 98.89 | 43.95 | 67.28 | 476.58 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.00 | 0.01 | 0.05 | 0.05 | 0.07 | 0.15 |
Debt / EBITDA Ratio | 0.01 | 0.04 | 0.37 | 0.28 | 0.26 | 0.69 |
Debt / FCF Ratio | 0.01 | 0.06 | 4.01 | 0.96 | 0.69 | 7.22 |
Net Debt / Equity Ratio | -0.32 | -0.17 | -0.27 | -0.33 | -0.14 | -0.10 |
Net Debt / EBITDA Ratio | -2.15 | -1.00 | -2.09 | -1.89 | -0.54 | -0.43 |
Net Debt / FCF Ratio | -3.11 | -1.27 | -22.76 | -6.48 | -1.45 | -4.53 |
Asset Turnover | 0.48 | 0.51 | 0.47 | 0.59 | 0.73 | 0.68 |
Inventory Turnover | 2.22 | 2.18 | 1.84 | 1.77 | 1.96 | 1.93 |
Quick Ratio | 2.81 | 1.70 | 1.96 | 2.54 | 0.84 | 0.96 |
Current Ratio | 3.91 | 3.51 | 2.97 | 3.81 | 1.80 | 1.81 |
Return on Equity (ROE) | 6.57% | 8.37% | 7.08% | 14.84% | 18.51% | 16.55% |
Return on Assets (ROA) | 5.35% | 6.16% | 4.07% | 7.34% | 8.58% | 7.54% |
Return on Invested Capital (ROIC) | 10.51% | 12.50% | 9.89% | 18.58% | 19.54% | 15.84% |
Return on Capital Employed (ROCE) | 10.00% | 11.90% | 7.90% | 12.00% | 18.00% | 14.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.50% | 4.63% | 4.95% | 4.75% | 2.60% | 1.35% |
FCF Yield | 7.06% | 7.38% | 0.84% | 1.98% | 1.45% | 0.21% |
Dividend Yield | 1.33% | 1.69% | 2.28% | 2.23% | 1.03% | 0.49% |
Payout Ratio | 45.28% | 61.69% | 77.76% | 37.37% | 25.50% | 30.07% |
Buyback Yield / Dilution | 0.44% | 0.11% | -0.07% | -7.33% | 0.50% | -3.00% |
Total Shareholder Return | 1.77% | 1.80% | 2.22% | -5.10% | 1.54% | -2.51% |